Imbalanced_JJ
expression_NN
of_IN
the_DT
glucocorticoid_NN
receptor_NN
isoforms_NNS
in_IN
cultured_VBN
lymphocytes_NNS
from_IN
a_DT
patient_NN
with_IN
systemic_JJ
glucocorticoid_NN
resistance_NN
and_CC
chronic_JJ
lymphocytic_JJ
leukemia_NN
._.

The_DT
human_JJ
glucocorticoid_NN
receptor_NN
-LRB-_-LRB-
GR_NN
-RRB-_-RRB-
is_VBZ
expressed_VBN
as_IN
two_CD
alternatively_RB
spliced_VBN
isoforms_NNS
,_,
GRalpha_NN
and_CC
GRbeta_NN
._.

Whereas_IN
GRalpha_NN
is_VBZ
a_DT
hormone-activated_JJ
transcription_NN
factor_NN
,_,
GRbeta_NN
does_VBZ
not_RB
bind_VB
glucocorticoids_NNS
-LRB-_-LRB-
GCs_NNS
-RRB-_-RRB-
,_,
is_VBZ
transcriptionally_RB
inactive_JJ
,_,
and_CC
is_VBZ
a_DT
potential_JJ
inhibitor_NN
of_IN
activated_VBN
GRalpha_NN
._.

Differential_JJ
expression_NN
of_IN
GR_NN
isoforms_NNS
may_MD
play_VB
a_DT
role_NN
in_IN
generalized_JJ
or_CC
tissue-specific_JJ
GC_NN
resistance_NN
._.

GCs_NNS
induce_VBP
apoptosis_NN
in_IN
neoplastic_JJ
lymphoid_JJ
cells_NNS
;_:
and_CC
,_,
defective_JJ
apoptosis_NN
is_VBZ
implicated_VBN
in_IN
the_DT
genesis_NN
of_IN
chronic_JJ
lymphocytic_JJ
leukemia_NN
-LRB-_-LRB-
CLL_NN
-RRB-_-RRB-
._.

We_PRP
studied_VBD
a_DT
patient_NN
with_IN
generalized_VBN
GC_NN
resistance_NN
and_CC
CLL_NN
._.

GR_NN
number_NN
in_IN
the_DT
patient_NN
's_POS
transformed_VBN
lymphocytes_NNS
was_VBD
approximately_RB
one_CD
half_NN
that_DT
of_IN
control_NN
cells_NNS
with_IN
a_DT
approximately_RB
10-fold_JJ
reduction_NN
in_IN
binding_NN
affinity_NN
for_IN
dexamethasone_NN
._.

In_FW
vitro_FW
apoptosis_NN
induction_NN
in_IN
CLL_NN
cells_NNS
was_VBD
delayed_VBN
in_IN
response_NN
to_TO
GCs_NNS
,_,
but_CC
not_RB
to_TO
other_JJ
apoptosis_NN
inducers_NNS
._.

Sequencing_NN
of_IN
the_DT
GR_NN
cDNA_NN
and_CC
gene_NN
including_VBG
the_DT
2.3-kb_JJ
coding_NN
region_NN
,_,
the_DT
intron\/exon_NN
junctions_NNS
,_,
the_DT
known_JJ
5_CD
'_``
-_NN
regulatory_JJ
region_NN
,_,
and_CC
approximately_RB
300_CD
bp_NN
of_IN
the_DT
3_CD
'_''
-_:
region_NN
revealed_VBD
no_DT
alterations_NNS
._.

Western_NN
blot_NN
with_IN
an_DT
N-terminal_JJ
antibody_NN
showed_VBD
normal_JJ
levels_NNS
of_IN
immunoreactive_JJ
GR_NN
,_,
but_CC
quantitative_JJ
analysis_NN
with_IN
isoform-specific_JJ
C-terminal_JJ
antibodies_NNS
revealed_VBD
a_DT
markedly_RB
reduced_VBN
GRalpha_NN
expression_NN
,_,
and_CC
high_JJ
GRbeta_NN
expression_NN
._.

These_DT
findings_NNS
indicate_VBP
that_IN
imbalanced_JJ
expression_NN
of_IN
the_DT
GR_NN
isoforms_NNS
may_MD
be_VB
a_DT
mechanism_NN
of_IN
GC_NN
resistance_NN
,_,
and_CC
may_MD
have_VB
implications_NNS
for_IN
tumorigenesis_NN
by_IN
enhancing_VBG
cell_NN
survival_NN
._.

Copyright_NN
1999_CD
Academic_NNP
Press_NNP
._.

